Tag: Nigel Parker
Firms advise on GSK’s USD2.2bn RAPT buy, accesses China drug
British pharmaceutical giant GSK has entered an agreement to acquire US-based clinical-stage biopharmaceutical company RAPT Therapeutics for around USD2.2 billion
A&G, A&O Shearman act on USD7.8bn semiconductor JV
Allen & Gledhill and A&O Shearman advised on a USD7.8B joint venture for a new semiconductor wafer facility in Singapore


















